Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-238K
-
Total reported value, excl. options
-
$4.26B
-
Value change
-
-$43.9M
-
Put/Call ratio
-
0.94
-
Number of buys
-
144
-
Number of sells
-
-125
-
Price
-
$226.31
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2017
310 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2017.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
.
Largest 10 shareholders include BlackRock Inc. (1.74M shares), VANGUARD GROUP INC (1.68M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.65M shares), ACADIAN ASSET MANAGEMENT LLC (894K shares), FMR LLC (711K shares), TimesSquare Capital Management, LLC (622K shares), ARIEL INVESTMENTS, LLC (574K shares), STATE STREET CORP (545K shares), WELLS FARGO & COMPANY/MN (524K shares), and UBS ASSET MANAGEMENT AMERICAS INC (427K shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.